Net proceeds of 86 m (indicated above) corresponds to the sale price* (154 m) after repayment of strategy financial liability (47 m), income tax (19 m) and transaction cost (2 m).
The low valuation of the company seems to be, in particular, explained by the high level of net debt. Before this transaction, they had a net debt of 47 m (before the impact of strategy financial liability).
* transaction still subject to regulatory approval. Expected to settle in several tranches until Sept 24.
- Forums
- ASX - By Stock
- MWY
- Ann: Investor Conference for Plantation Estate
Ann: Investor Conference for Plantation Estate, page-3
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MWY (ASX) to my watchlist
(20min delay)
|
|||||
Last
76.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.81M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4583 | 76.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4583 | 0.765 |
2 | 16940 | 0.760 |
2 | 5000 | 0.750 |
2 | 3202 | 0.740 |
1 | 5000 | 0.735 |
Price($) | Vol. | No. |
---|---|---|
0.780 | 15000 | 1 |
0.790 | 22700 | 1 |
0.795 | 15000 | 1 |
0.800 | 12398 | 2 |
0.830 | 6900 | 1 |
Last trade - 16.12pm 13/11/2024 (20 minute delay) ? |
Featured News
MWY (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online